Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wojtek Rakowicz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|January 14, 2012
Post-traumatic dizzinessSimon William Dubrey, Wojtek Rakowicz
The Cochrane Database of Systematic Reviews|July 23, 2008
Treatment for meralgia paraestheticaNofal Khalil, Alessia Nicotra, Wojtek Rakowicz
The Cochrane Database of Systematic Reviews|December 14, 2012
Treatment for meralgia paraestheticaNofal Khalil, Alessia Nicotra, Wojtek Rakowicz
Muscle & Nerve|February 15, 2007
Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromesRobert H Baloh, Wojtek Rakowicz, Robert Gardner, et al.
Postgraduate Medical Journal|November 8, 2013
Lyme disease in the United KingdomSimon W Dubrey, Ajay Bhatia, Sarah Woodham, et al.
Muscle & Nerve|December 31, 2024
Long-Term Outcomes From a Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) Compared to Standard Medical Care for Improving Quality of Life in Muscle DisordersChristopher D Graham, Michael Rose, Victoria Edwards, et al.
Psychological Medicine|February 22, 2022
A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseasesMichael Rose, Christopher D Graham, Nicola O'Connell, et al.
Frontiers in Psychology|December 18, 2023
Participant experiences of guided self-help Acceptance and Commitment Therapy for improving quality of life in muscle disease: a nested qualitative study within the ACTMus randomized controlled trialVictoria Edwards, Chiara Vari, Michael Rose, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Mobility shift of beta-dystroglycan as a marker of <i>GMPPB</i> gene-related muscular dystrophyAnna Sarkozy, Silvia Torelli, Rachael Mein, et al.
Human Mutation|April 5, 2012
Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathiesAndrea Klein, Suzanne Lillis, Iulia Munteanu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|January 14, 2012
Post-traumatic dizzinessSimon William Dubrey, Wojtek Rakowicz
The Cochrane Database of Systematic Reviews|July 23, 2008
Treatment for meralgia paraestheticaNofal Khalil, Alessia Nicotra, Wojtek Rakowicz
The Cochrane Database of Systematic Reviews|December 14, 2012
Treatment for meralgia paraestheticaNofal Khalil, Alessia Nicotra, Wojtek Rakowicz
Muscle & Nerve|February 15, 2007
Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromesRobert H Baloh, Wojtek Rakowicz, Robert Gardner, et al.
Postgraduate Medical Journal|November 8, 2013
Lyme disease in the United KingdomSimon W Dubrey, Ajay Bhatia, Sarah Woodham, et al.
Muscle & Nerve|December 31, 2024
Long-Term Outcomes From a Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) Compared to Standard Medical Care for Improving Quality of Life in Muscle DisordersChristopher D Graham, Michael Rose, Victoria Edwards, et al.
Psychological Medicine|February 22, 2022
A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseasesMichael Rose, Christopher D Graham, Nicola O'Connell, et al.
Frontiers in Psychology|December 18, 2023
Participant experiences of guided self-help Acceptance and Commitment Therapy for improving quality of life in muscle disease: a nested qualitative study within the ACTMus randomized controlled trialVictoria Edwards, Chiara Vari, Michael Rose, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Mobility shift of beta-dystroglycan as a marker of <i>GMPPB</i> gene-related muscular dystrophyAnna Sarkozy, Silvia Torelli, Rachael Mein, et al.
Human Mutation|April 5, 2012
Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathiesAndrea Klein, Suzanne Lillis, Iulia Munteanu, et al.
Pageof 2